Important. Read and act.
“Prior authorization is the No. 1 burden to physician practice and a major impediment to the patient-physician relationship and patient care.” https://t.co/SOITVxOvLz
#AIBDRegionals These slides from @tinahamd Keynote are 💎💎💎💎💎
🪜How to position therapies in
✅Low risk UC
✅High risk UC
⚖️Balance efficacy & safety of the different MOA of #UlcerativeColitis
💬Thoughts ? @IBDConference
So can we all agree to not deny pregnant IBD pts biologics now? First @Y_ECCO_IBD guidelines change & now great study @AnnalsofIM by French group (A. Meyer - 5293 TNF exposed pregnancies). Stopping drug by 24w lead to⬆️dx activity and⬆️preterm birth. Cont. tx➡️healthy 🤰 ➡️👶!
Teenager w EoE & complete symptom resolution on BID PPI but repeat histology still shows Eos>15/hpf. Should we 🎯histologic response to prevent future complications or escalate Rx only if symptoms return? @AmCollegeGastro#GITwitter@AGA_CGH@AGA_Gastro
IBS remains an enigma esp for female population requiring a lot of patience and experimentation from both patients and HCPs. My take on IBS. Can get even more challenging with coexisting IBD! https://t.co/zv2eNP4bvk #GITwitter@AmCollegeGastro#gastroenterology@MondayNightIBD